I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.345 USD -6.6% Market Closed
Market Cap: 61.3m USD
Have any thoughts about
InterCure Ltd?
Write Note

Intrinsic Value

The intrinsic value of one INCR stock under the Base Case scenario is 4.972 USD. Compared to the current market price of 1.345 USD, InterCure Ltd is Undervalued by 73%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INCR Intrinsic Value
4.972 USD
Undervaluation 73%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
InterCure Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for INCR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about INCR?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about InterCure Ltd

Provide an overview of the primary business activities
of InterCure Ltd.

What unique competitive advantages
does InterCure Ltd hold over its rivals?

What risks and challenges
does InterCure Ltd face in the near future?

Summarize the latest earnings call
of InterCure Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InterCure Ltd.

Provide P/S
for InterCure Ltd.

Provide P/E
for InterCure Ltd.

Provide P/OCF
for InterCure Ltd.

Provide P/FCFE
for InterCure Ltd.

Provide P/B
for InterCure Ltd.

Provide EV/S
for InterCure Ltd.

Provide EV/GP
for InterCure Ltd.

Provide EV/EBITDA
for InterCure Ltd.

Provide EV/EBIT
for InterCure Ltd.

Provide EV/OCF
for InterCure Ltd.

Provide EV/FCFF
for InterCure Ltd.

Provide EV/IC
for InterCure Ltd.

Show me price targets
for InterCure Ltd made by professional analysts.

What are the Revenue projections
for InterCure Ltd?

How accurate were the past Revenue estimates
for InterCure Ltd?

What are the Net Income projections
for InterCure Ltd?

How accurate were the past Net Income estimates
for InterCure Ltd?

What are the EPS projections
for InterCure Ltd?

How accurate were the past EPS estimates
for InterCure Ltd?

What are the EBIT projections
for InterCure Ltd?

How accurate were the past EBIT estimates
for InterCure Ltd?

Compare the revenue forecasts
for InterCure Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InterCure Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InterCure Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of InterCure Ltd compared to its peers.

Compare the P/E ratios
of InterCure Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing InterCure Ltd with its peers.

Analyze the financial leverage
of InterCure Ltd compared to its main competitors.

Show all profitability ratios
for InterCure Ltd.

Provide ROE
for InterCure Ltd.

Provide ROA
for InterCure Ltd.

Provide ROIC
for InterCure Ltd.

Provide ROCE
for InterCure Ltd.

Provide Gross Margin
for InterCure Ltd.

Provide Operating Margin
for InterCure Ltd.

Provide Net Margin
for InterCure Ltd.

Provide FCF Margin
for InterCure Ltd.

Show all solvency ratios
for InterCure Ltd.

Provide D/E Ratio
for InterCure Ltd.

Provide D/A Ratio
for InterCure Ltd.

Provide Interest Coverage Ratio
for InterCure Ltd.

Provide Altman Z-Score Ratio
for InterCure Ltd.

Provide Quick Ratio
for InterCure Ltd.

Provide Current Ratio
for InterCure Ltd.

Provide Cash Ratio
for InterCure Ltd.

What is the historical Revenue growth
over the last 5 years for InterCure Ltd?

What is the historical Net Income growth
over the last 5 years for InterCure Ltd?

What is the current Free Cash Flow
of InterCure Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for InterCure Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InterCure Ltd

Current Assets 418.8m
Cash & Short-Term Investments 101.3m
Receivables 201.5m
Other Current Assets 116m
Non-Current Assets 367.8m
Long-Term Investments 20.4m
PP&E 97.5m
Intangibles 221.1m
Other Non-Current Assets 28.9m
Current Liabilities 225.9m
Accounts Payable 133.6m
Other Current Liabilities 92.3m
Non-Current Liabilities 105.6m
Long-Term Debt 102.8m
Other Non-Current Liabilities 2.8m
Efficiency

Earnings Waterfall
InterCure Ltd

Revenue
355.6m ILS
Cost of Revenue
-247.2m ILS
Gross Profit
108.3m ILS
Operating Expenses
-74.1m ILS
Operating Income
34.3m ILS
Other Expenses
-96.2m ILS
Net Income
-62m ILS

Free Cash Flow Analysis
InterCure Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

INCR Profitability Score
Profitability Due Diligence

InterCure Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Positive Operating Income
50/100
Profitability
Score

InterCure Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

INCR Solvency Score
Solvency Due Diligence

InterCure Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
44/100
Solvency
Score

InterCure Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for INCR?

Click here to dive deeper.

Dividends

InterCure Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for INCR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

InterCure Ltd

Country

Israel

Industry

Pharmaceuticals

Market Cap

244m ILS

Dividend Yield

0%

Description

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Contact

Herzliya
Medinat HaYehudim 85
+972774605012.0
www.intercure.co

IPO

2007-07-26

Employees

75

Officers

CEO & Director
Mr. Alexander Rabinovich
Chief Financial Officer
Mr. Amos Cohen
Vice President of Sales
Einat Zehavi

See Also

Discover More
What is the Intrinsic Value of one INCR stock?

The intrinsic value of one INCR stock under the Base Case scenario is 4.972 USD.

Is INCR stock undervalued or overvalued?

Compared to the current market price of 1.345 USD, InterCure Ltd is Undervalued by 73%.

Back to Top